<a href=Toshiba” height=”400″ src=”https://www.medicaldevice-network.com/wp-content/uploads/static-progressive/nri/medicaldevice/news/450px-TOSHIBA_.jpg” width=”300″ />

Long Beach Memorial, a primary stroke care centre for MemorialCare Health System, has selected Toshiba’s Aquilion ONE dynamic volume CT system for comprehensive diagnosis and treatment planning for acute stroke patients.

The Aquilion ONE CT system, which features Target CTA, SUREExposure 3D, SUREExposure Pediatric, QDS and Boost3D dose reduction technologies, uses 320 ultra-high-resolution, 0.5mm detector elements to cover up to 16cm of anatomy and to image the entire brain in a single rotation.

MemorialCare Neuroscience Institute, Long Beach Memorial spokesperson, Nima Ramezan, said the Aquilion ONE’s whole brain perfusion images and ability to show real-time brain function with greater detail are instrumental in improving stroke diagnoses and planning.

"We also use the system to assess therapy effectiveness to further guide our decision making for improved patient outcome and the patient’s recovery process," added Ramezan.

Long Beach Memorial said that it will soon upgrade the Aquilion ONE system with Toshiba’s new dose reduction technology, Adaptive Iterative Dose Reduction 3D (AIDR 3D), which will allow the facility to acquire CT data sets using less radiation, helping to improve patient safety.

Toshiba CT business unit market development senior manager, Tim Nicholson, said that Aquilion ONE revolutionises patient care by helping to reduce diagnoses times for life-threatening conditions, such as stroke, from hours to minutes.

"The Aquilion ONE can improve quality of life for stroke patients through its faster, more comprehensive exams, ultimately resulting in lower overall healthcare costs and better patient outcomes," Nicholson added.

Image: Toshiba’s headquarters in Tokyo, Japan. Photo courtesy of: Lover of Romance.